|
|
|
|
| LEADER |
01000naa a22002652 4500 |
| 001 |
NLM031093914 |
| 003 |
DE-627 |
| 005 |
20231221115557.0 |
| 007 |
tu |
| 008 |
231221s1987 xx ||||| 00| ||jpn c |
| 028 |
5 |
2 |
|a pubmed24n0104.xml
|
| 035 |
|
|
|a (DE-627)NLM031093914
|
| 035 |
|
|
|a (NLM)3128071
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a jpn
|
| 100 |
1 |
|
|a Nakagami, Y
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Clinical experience of tegafur-uracil (UFT) against bladder cancer and renal cell carcinoma
|
| 264 |
|
1 |
|c 1987
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 03.05.1988
|
| 500 |
|
|
|a Date Revised 21.11.2013
|
| 500 |
|
|
|a published: Print
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 520 |
|
|
|a The safety of prolonged administration of UFT in which tegafur and uracil were mixed in a ratio of 1:4 in molar fraction was studied in 44 cases of bladder cancer and 10 cases of renal cell carcinoma. Daily doses of UFT were 300-600 mg, and average total doses administered were 102.0 g for bladder cancer and 116.6 g for renal cell carcinoma cases. Incidence of adverse effects were 25.0% in bladder cancer and 18.5% in renal cell carcinoma cases. Anorexia, nausea, vomiting and decrease in WBC were observed, but rates of having discontinued the administration of UFT were very low, being 9.1% in bladder cancer and 10.0% in renal cell carcinoma. Thus, UFT was considered to be tolerable during prolonged use in bladder cancer and renal cell carcinoma and also a drug in which more usefulness is expected in multidisciplinary treatments in future
|
| 650 |
|
4 |
|a English Abstract
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
7 |
|a Tegafur
|2 NLM
|
| 650 |
|
7 |
|a 1548R74NSZ
|2 NLM
|
| 650 |
|
7 |
|a Uracil
|2 NLM
|
| 650 |
|
7 |
|a 56HH86ZVCT
|2 NLM
|
| 700 |
1 |
|
|a Lin, T T
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Ito, H
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Hirasawa, S
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Tannawa, K
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Fujioka, Y
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Ogawa, H
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Tanaka, K
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Yamada, N
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Ishii, Y
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Hinyokika kiyo. Acta urologica Japonica
|d 1962
|g 33(1987), 10 vom: 01. Okt., Seite 1728-32
|w (DE-627)NLM012631779
|x 0018-1994
|7 nnns
|
| 773 |
1 |
8 |
|g volume:33
|g year:1987
|g number:10
|g day:01
|g month:10
|g pages:1728-32
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_20
|
| 912 |
|
|
|a GBV_ILN_22
|
| 912 |
|
|
|a GBV_ILN_40
|
| 912 |
|
|
|a GBV_ILN_60
|
| 912 |
|
|
|a GBV_ILN_72
|
| 912 |
|
|
|a GBV_ILN_120
|
| 912 |
|
|
|a GBV_ILN_350
|
| 912 |
|
|
|a GBV_ILN_2001
|
| 912 |
|
|
|a GBV_ILN_2003
|
| 912 |
|
|
|a GBV_ILN_2005
|
| 912 |
|
|
|a GBV_ILN_2006
|
| 912 |
|
|
|a GBV_ILN_2008
|
| 912 |
|
|
|a GBV_ILN_2010
|
| 912 |
|
|
|a GBV_ILN_2012
|
| 912 |
|
|
|a GBV_ILN_2018
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 33
|j 1987
|e 10
|b 01
|c 10
|h 1728-32
|